Striascan 74 MBq/ml, Injektionslösung

7680685930019 CH-68593 Injektionslösung
Striascan 74 MBq/ml, Injektionslösung
Striascan 74 MBq/ml, Injektionslösung
Striascan 74 MBq/ml, Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
11/04/2025
Summary of Product Characteristics
Français
11/04/2025
Summary of Product Characteristics
Italien
11/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
185.0 MBQ Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
98.75 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
4.9 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 891.85
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/05/2023

Authorization holder

b.e.imaging.ag

6430 Schwyz

Authorization information

Swissmedic authorization number
68593
Drug name
Striascan 74 MBq/ml, Injektionslösung
Galenic form
LSINJ
ATC Code
V09AB03
Authorization status
Z
Dispensing category
A
First authorization
09/09/2022
Authorization expiration date
08/09/2027
IT Number
17.01.1.
Domain
Human medicine
Field of application
Untersuchung dopaminerger Neuronenendigungen im Striatum von Patienten mit klinisch unklaren Parkinson-Symptomen

Package details

Description (FR)
STRIASCAN sol inj 74 MBq/ml flac 2.5 ml
Description (DE)
STRIASCAN Inj Lös 74 MBq/ml Durchstf 2.5 ml
Market launch
09/09/2022
Narcotic (BTM)
No

Original drug

DaTSCAN TM 123 I-Ioflupane (INN), Injektionslösung
GTIN: 7680557170024
CHF 1084.05
View original